HUBUNGAN DRUG RELATED PROBLEMS DENGAN OUTCOME TERAPI PADA PASIEN DIABETES

MELITUS TIPE 2 DENGAN 87

HIPERTENSI RAWAT INAP DI RUMAH SAKIT PKU MUHAMMADIYAH YOGYAKARTA
SUGENG RUSPANDI
Universitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/

DAFTAR PUSTAKA

Adham, M., Froelicher, E.S., Batieha, A., dan Ajlouni, K., 2010, Glycaemic
control and its associated factors in type 2 diabetic patient in Amman,
Jordan, EMHJ, 6, 732-739.
Ado, M.W., 2012, Identifikasi Drug Related Problems pada Pasien Pediatrik di
Bangsal Rawat Inap RSUD Abunawas Kendari Periode November 2011-
Januari 2012, Tesis, Program Pascasarjana Fakultas Farmasi Universitas
Gadjah Mada, Yogyakarta.
Ahmad, N.S., Islahudin, F., dan Paraidhatathu, T., 2014, Factor Associated with
good glycemic control among patient with type 2 diabetes mellitus, J
Diabetes Invest, 5, 563-569.
Ahren, B., Simosson, E., Larsson, H., Olsson, M. L., Torgeirsson, H., Jansson, P.
A., Sandqvist, M., Bahenvolm, P., Efendic, S., Eriksson, J.W., Dickinsson,
S., Holmes, D., 2002, Emerging Treatment and Technologies : Inhibition
of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week
Study Period in Type 2 Diabetes, Diabetes Care, 25(5), 869-875.
Ali, M.K., Bullard, K.M., Saaddine, J.B., Cowie, C.C., Imperatore, G., dan Gregg,
E.W., 2013, Achievment of Goals in U.S. Diabetes Care 1999-2010, N
Engl J Med, 368, 1613-1624.
Al-Mahroos F., Al-Roomi K., dan McKeigue P.M., 2000, Relation of high blood
pressure to glucose intolerance, plasma lipid, and educational status in an
Arabian Gulf population, International Journal Of Epidemiology, 29, 71-
76.
American Diabetes Association, 2009, Standard of Medical Care in Diabetes,
Diabetes Care, volume 32(suppl. 1), S13-S47.
American Diabetes Association, 2012, Standards of medical care in diabetes-
2012, Diabetes Care, 35(suppl. 1), S11-S63.
American Diabetes Association, 2014, Standard of Medical Care in Diabetes-
2014, Diabetes Care,37(suppl.1), S14-S62.
American Diabetes Association, 2015, Standards of medical care in diabetes-
2015, Diabetes Care, 38(suppl.1), S1-S2.
Anonim, 2007, Farmakologi dan Terapi, UI Press, Jakarta.
Anonim, 2008, ISO Farmakoterapi, PT ISFI Penerbitan, Jakarta.
Anonim, 2010, Diagnosis and Classification of Diabetes Mellitus, Diabetes Care,
33, 62.
 HUBUNGAN DRUG RELATED PROBLEMS DENGAN OUTCOME TERAPI PADA PASIEN DIABETES
MELITUS TIPE 2 DENGAN 88
HIPERTENSI RAWAT INAP DI RUMAH SAKIT PKU MUHAMMADIYAH YOGYAKARTA
SUGENG RUSPANDI
Universitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/

Anonim, 2011, Medical Guidelines for Clinical for Developing a Diabetes

Mellitus Comprehensive Care Plan, American Association of Clinical
Endocrinologist (AACE).
Anonim, 2014, Are You At Risk : Lower Your Risk, http://www.diabetes.org/are-
you-at-risk/lower-your-risk/nonmodifiables.htm#Gender, 5 Mei 2015.
Asdie, A.H., 2000, Patogenesis dan Terapi Diabetes Melitus Tipe 2, 18-45,
Fakultas Kedoteran Univeritas Gadjah Mada, Yogyakarta.
Barnett, A.H., Bain, S.C., Bouther, P., Karlbers, B., Madibad, S., Jervel, S.,
Mustonen, J., 2004, Angiotensin-Receptor Blockade versus Converting-
Enzyme Inhibition in Type 2 Diabetes and Nephropathy, N ENGL J MED
351, 52-61.
Benowitz, N.L., 2007, Antihypertensive Agent, dalam Katzung, B.G., Basic &
Clinical Pharmacology, 10th edition, 159-182, McGraw-Hill Companies,
New York.
Boucher, 2009, Integrating Food and Medication as A Way of A Life, Clinical
Diabetes, 27 (4), 129-130.
Brunton, L., Parker, K.L., Buxton, I., Blumenthal, D.L., 2008, Manual
pharmacology and theraupeutic Goodman and Gilaman, The McGraw-
Hill, Companies, United States of America.
Cavanaugh, K.L., 2007, Diabetes Management Issues for Patient With Chronic
Kidney Disease, Clinical Diabetes, 25 (3), 90-97.
Centers for Disease Control and Prevention, 2014, National Diabetes Statistics
Report: Estimates of Diabetes and Its Burden in the United States 2014,
Department of Health and Human Services, Atlanta, GA: U.S.
Chan, D.C., Chen J.H., Kuo H.K., We C.J., Lu I.S., Chiu L.S., Wu, S.C., 2011,
Drug-related problems (DRPs) identified from geriatric medication safety
review clinics, Arh Gerontol Geriatr 54:168-174 cit Zaman Huri dan Fun
Wee, 2013, Drug related problems in type 2 diabetes patient with
hypertension: a cross-sectional retrospective study, BMC Endocrine 13 : 2.
Chobanian, A. V., Bakri, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo,
J.L., Jones, D.W., Materson, B.J., Oparil, S., dan Wright. J.T., 2003,
Seventh Report of The Joint National Committe on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure, Hypertension, 42,
1206-1252.
Cipolle R.J., Stand L.M., dan Morley P.C., 1998, Pharmaceutical care Practice,
The McGraw-Hill Companies, New York.
 HUBUNGAN DRUG RELATED PROBLEMS DENGAN OUTCOME TERAPI PADA PASIEN DIABETES
MELITUS TIPE 2 DENGAN 89
HIPERTENSI RAWAT INAP DI RUMAH SAKIT PKU MUHAMMADIYAH YOGYAKARTA
SUGENG RUSPANDI
Universitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/

Cipolle, R.J., Strand, L.M., dan Frakes, M.J., 2007, Comorbidities and Drug
Therapy Problems in Patients with Diabetes, 1-10, Medication
Management System, Inc.
Cipolle, R.J., Strand, L.M., Frakes, M.J., 2013, Diabetes: Co-morbidities and
Drug Therapy Prolems in Patient with Diabetes, Medication Management
System. Inc.
Cipolle, R.J., Strand, L.M., dan Morley, P.C., 2004, Pharmaceutical Care
Practice :The Clinician’s Guide 2nd edition, McGraw-Hill Medical
Publishing Division.
Craig, K.J., Williams, J.D., Riley, S.G., Smith, H., Owens, D.R., Whorthing, D.,
Cavill, I., Phillips, A.O., 2005, Anemia and Diabetes in the Absence of
Nephropathy, Diabetes Care, 28 (5), 1118-1123.
Depkes, 2005a, Pharmaceutical Care untuk Penyakit Diabetes Melitus,
Departemen Kesehatan RI, Jakarta.
Depkes, 2005b, Pharmaceutical Care untuk Penyakit Hipertensi, Departemen
Kesehatan RI, Jakarta.
Deray, G., Heartier, A., Grimaldi, A., Launay, V.V., Isnard, B.C., 2004, Anemia
and Diabetes, Am J Neprol, 24 (2), 522-526.
DeWitt, D.E., dan Hirsch, I.B., 2003, Outpatient Insulin Therapy in Type 1 and
Type 2 Diabetes Mellitus, JAMA, 389 (17), 2254-2271.
Dincer, H.E., Dincer, A.P., dan Levinson, D.J., 2002, Asymptomatic
hyperurisemia: To treat or not to treat, Clevel Clin Jour of Med, 69 (8),
594-602.
DiPiro, C.V., 2012, Anemias, dalam Wells, B.G., Dipiro, J.T., Schwinghammer,
T.C., Pharmacotherapy Handbook, 8th edition, 1496-1592, Mc Graw Hill,
New York.
Dipiro, J.T., Wells, B.G., Schwinghammer, T.L., Dipiro, C.V., 2009,
Pharmcoteraphy handbook Seven Edition, The McGraw-Hill Companies,
United States of America.
Dowling, T.C., dan Comstock, T.J., 2009, Quantification of Renal Fungtion,
dalam DiPiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G.,
Posey, L.M., Pharmacotherapy A Pathophysiologic Approach, 6th edition,
761-780, McGraw-Hill, New York.
Eid M., Mafauzy M., dan Faridah A.R., 2004, Non-Achievement of Clinical
Targets in Patient With Type 2 Diabetes Melitus, Med J Malaysia, 59,
177-184.
 HUBUNGAN DRUG RELATED PROBLEMS DENGAN OUTCOME TERAPI PADA PASIEN DIABETES
MELITUS TIPE 2 DENGAN 90
HIPERTENSI RAWAT INAP DI RUMAH SAKIT PKU MUHAMMADIYAH YOGYAKARTA
SUGENG RUSPANDI
Universitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/

Epstein, M., dan Sowers J.R., 1992, Diabetes mellitus and hypertension,
Hypertension, 19, 403-418.
Ernst F.R., dan Grizzle A.J., 2001, Drug-related morbidity and mortality: updating
the cost-of-illness model, J Am Pharm Assoc 41 (2): 192-199 cit Zaman
Huri dan Fun Wee, 2013, Drug related problems in type 2 diabetes patient
with hypertension: a cross-sectional retrospective study, BMC Endocrine
13, 1-12.
European Society of Cardiology, 2000, Dihydropyridine calcium-channel
blockers for the treatment of hypertensive diabetic patient, European
Hearth Journal, 21, 2-7.
Fillenbaum G., Pieper C., Cohen H., Comoni-Huntley J., Guralnik J., 2000,
Comorbidity of five chronic health conditition in elderly community
resident: determinant and impact on mortality, J Gerontol A Biol Sci Med
Sci, 55, M84-89.
Fishbane, S., 2010, The role of erytropoiesis-stimulating agents in the treatment of
anemia, Am J Manag Care, 16, S67-73.
Grundy, S.M., Becker, D., Clark, L.T., Cooper, R.S., Denke, M.A., Howard,
W.M., Hunninghake, D.B., Illingworth, D.R., Luepker, R.V., McBride, P.,
McKenney, J.M., Pasternak, R.C., Stone, N.J., Horn, L.V., 2000, Third
Report of The National Cholesterol Education Program (NCEP) Expert
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol
in Adults (Adult Treatment Panel III), Circulation, 17, 3157-3373.
Gunar, S., dan Rosa, L.G., Clinical pharmacy and activities in chronic kidney
disease and end-stage renal disease patient: A systematic literature review,
BioMed Central Nephrol, 12 (35), 1-12.
Hassing L.B., Havet, S.M., Nilsson, S.E., Berg, S., Pedersen, N.L., McClearn, G.,
Johanson, B., 2004, Comorbid type 2 diabetes mellitus and hypertension
exacerbates cognitive decline: evidence from a longitudinal study, Age and
Ageing, 33, 355-361.
Hermann, L.S., Schersten, B., Bitzeh, P.O., Kjellstrom, T., Lindgarge, F.,
Melander, A., 1994, Therapeutic Comparation of Metformin and
Sulfonylurea Alone and in Various Combination, Diabetes Care, 17 (10),
1100-1110.
Hoffman, B.B., 2006, Therapy of Hypertension, dalam Brunton, L.L., Lazo, J.S.,
Parker, K.L., Goodman & Gilman’s The Pharmacological Basis of
Therapeutics, 11th edition, McGraw-Hill, New York.
Huri, H.Z dan Hoo F.W, 2013, Drug related problems in type 2 diabetes patient
with hypertension: a cross-sectional retrospective study, BMC Endocrine
13, 1-12.
 HUBUNGAN DRUG RELATED PROBLEMS DENGAN OUTCOME TERAPI PADA PASIEN DIABETES
MELITUS TIPE 2 DENGAN 91
HIPERTENSI RAWAT INAP DI RUMAH SAKIT PKU MUHAMMADIYAH YOGYAKARTA
SUGENG RUSPANDI
Universitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/

James, P.A., Oparil, S., Carter, B.L., Cushman, W.C., Himmelfarb, C.D., Handler,
J., Lackland, D.T., LeFevre, M.L., MacKenzie, T.D., Ogedegbe, O.,
Smith, S.C., Svetey, L.P., Taler, S.J., Townsend, R.R., Wright, J.T., Narva,
A.S., Ortis, E., 2013, 2014 Evidence-Based Guideline for the Management
of High Bood Pressure in Adult Report From the Panel Members
Appointed to the Eight Joint National Committe (JNC-8), American
Medical Association, JAMA, E1-E14.
Jellinger, P.S., Smith, D.A., Mehta, A.E., Garda Om, Handelsman, Y., Rodbard,
H.W., Shepherd, M.D., Selbel, J.A., 2012, American Association of
Clinical Endocrinologists Guideline for Management of Dyslipidemia and
Prevention of Atherosclerosis, Endocr Pract, 18 (Suppl. 1), 1-78.
Karen, L. W., dan Stewatr, R. D., 2008, Pharmacologic Management of
Hypertension in Patient with Diabetes, Am Fam Phyician 78 (11),1277-
1282.
KDIGO (Kidney Disease Improving Global Outcome), 2012, Clinical Practice
Guideline for Anemia In Chronic Kidney Disease, Journal of the
International Society of Nephrology, 2 (4), 279-331.
Kearney, P. M., M. Whelton, K. Reynolds, P. Muntner, P. K. Whelton dan J. He,
2005, Global burden of hypertension: analysis of worldwide data, Lancet
365, 217-223.
Keith, G. T., Anthony, D., Vivian, F., Tan, M. H., 2007, Spectrum of liver disease
in type 2 diabetes and the management of patient with diabetes and liver
disease, Diabetes Care, 30 (3), 734-743.
Kemenkes, 2012, Buletin Jendela Data dan Informasi Kesehatan: Penyakit Tidak
Menular, Semester II, Kementrian Kesehatan RI, Jakarta.
Kemenkes, 2013, Riset Kesehatan Dasar Riskesdas 2013, Badan Penelitian dan
Pengembangan Kesehatan Kementrian Kesehatan RI, Jakarta.
Kroon, L.A. dan Williams, C., 2012, Diabetes Melllitus, dalam: Alldredge, B.K.,
Corelli, R.L., Erns, M.E. (Eds), Koda-Kimble and Young’s Applied
Therapeutics: The Clinical Use of Drugs, Lippincott Williams & Wilkins,
Philadelphia, pp. 1255.
Kurniawan, I., 2010, Diabetes Melitus Tipe 2 pada Usia Lanjut, Maj Kedokt
Indon, 60 (12), 576-584.
Lacy, L.F., Armstrong, L.L., Goldman, M.P., Lance. L.L., 2009, Drug
Information Handbook A Comprehensive Resource for All Clinicians and
Healthcare Professional, 17th edition, Lexi-comp.Inc, Ohio.
Lucas, C.P., Estigarriba J.A., Darga L.L., dan Reaven G.M., 1985, Insulin and
blood pressure in obesity, Hypertension, 7, 702-706.
 HUBUNGAN DRUG RELATED PROBLEMS DENGAN OUTCOME TERAPI PADA PASIEN DIABETES
MELITUS TIPE 2 DENGAN 92
HIPERTENSI RAWAT INAP DI RUMAH SAKIT PKU MUHAMMADIYAH YOGYAKARTA
SUGENG RUSPANDI
Universitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/

Magaji, V., dan Johnston, J.M., 2011, Inpatient Management of Hyperglicemia

and Diabetes, Clinical Diabetes, 29 (1), 3-7.
Mangesha, A.Y., 2007, Hypertension and related risk factors in type 2 diabetes
mellitus (DM) patient in Gaborone City Council (GCC) clinics, Gaborone,
Boswana, African Health Science, 7 (4), 244-245.
Mannuccini, E., Monami, M., Marchionni N., 2009, Short-acting insulin
analogues vs regular human insulin in type 2 diabetes : a meta-analysis,
Journal Compilation, 11, 53-59.
Mansjoer, A., Triyanti, K., Savitri, R., Wardhani, W.I., dan Setiowulan, W., 1999,
Kapita Selekta Kedokteran, Edisi III, Jilid Pertama, 518-523, Media
Aesculapius, Fakutas Kedokteran Universitas Indonesia, Jakarta.
Mayfield, J., 1998, Diagnosis and Classification of Diabetes Mellitus : New
Criteria, Am Fam Physician, 58 (6), 1355-1362.
Medicines and Healthcare Product Regulatory Agency, 2007, Ketoprofen and
ketorolac: gastrointestinal risk, https://www.gov.uk/drug-safety-
update/ketoprofen-and-ketorolac-gastrointestinal-risk, 12 Mei 2015.
Meneghini, L.F., 2009, Early Insulin Treatment in Type 2 Diabetes, Diabetes
Care, volume, 2 (supl 2), S266-S269.
Mohebbi, L., dan Hesch, K, 2009, Stress ulcer prophylaxis in the intensive care
unit, Proc (Bayl Univ Med Cent), 22 (4), 373-376.
Moura, C.S., Acurcio F.A., Belo N.O., 2009, Drug-drug interaction associated
with lenght of stay and cost hospitalization, J Pharm Pharm Sci,
12(3):266-272 cit Zaman Huri dan Fun Wee, 2013, Drug related problems
in type 2 diabetes patient with hypertension: a cross-sectional retrospective
study, BMC Endocrine, 13, 1-12.
Munger, M.A., Polipharmacy and combination theraphy in the management of
hypertension in elderly patien with Co-morbid diabetes mellitus, Drug
Aging 27(11):871-883 cit Zaman Huri dan Fun Wee, 2013, Drug related
problems in type 2 diabetes patient with hypertension: a cross-sectional
retrospective study, BMC Endocrine, 13, 1-12.
Nathan, D.M., Buse, J.B., Davidson, M. B., Ferrannini, E., Holman, R. R.,
Sherwin, R., Zinman, B., 2009, Medical Management of Hyperglicemia in
Type 2 Diabetes : A Consensus Algorithm for the Initiation and
Adjustment of Therapy, Diabetes Care, 52, 14-30.
NICE, 2012, Headache: Diagnosis and management of headches in young people
an adults, NICE Cinical Guideline, 150, 1-38.
 HUBUNGAN DRUG RELATED PROBLEMS DENGAN OUTCOME TERAPI PADA PASIEN DIABETES
MELITUS TIPE 2 DENGAN 93
HIPERTENSI RAWAT INAP DI RUMAH SAKIT PKU MUHAMMADIYAH YOGYAKARTA
SUGENG RUSPANDI
Universitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/

Niquille A., dan Buqnon O., 2010, Relationship between drug-related problems
and helath outcomes: a cross-sectional study among cardiovascular patient,
Pharmacy World & Science, 32, 512-519.
NKF (National Kidney Fondation), 2007, Diabetes and Chronic Kidney Disease
Stage 1-4, National Kidney Fondation. Inc, New York.
Oster, J.R., Materson, B.J., dan Epstein, M., 1990, Diabetes mellitus and
hypertension, Cardiovascular Risk Factors, l, 25-46.
Ozougwu, J.C., Obimba, K.C., Belonwu, C.D., Unakalamba, C.B., 2013, The
pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus,
J. Physiol.Pathiphysiol, 4 (4), 46-57.
Pablos-Velasco, P.D., Parhofer, K.G., Bradley, C., Eschwege, E., Frederick, L.G.,
Maheux, P., Wood, L., and Simon, D., 2014, Clin Endocrinol, 80, 47-56.
Perkeni, 2006, Konsensus Pegelolaan dan Pencegahan Diabetes Melitus tipe 2 di
Indonesia, 4, 17-24, dan 30-32, Perkumpulan Endokrinologi Indonesia.
Perkeni, 2011, Konsensus Pengendalian dan Pencegahan Dibetes Melitus Tipe 2
di Indonesia, Perkempulan Endokrinologi Indonesia.
Perwitasari, D.A., 2006, Pola Pengobatan Hipertensi dan Diabetes Melitus Tipe 2
pada Pasien Geriatrik R.S. Dr. Sardjito Jogjakarta, Majalah Farmasi
Indonesia, 5 (1), 61-68.
Petznick, A., 2001, Insulin Management of Type 2 Diabetes Mellitus , Am Fam
Physician 84 (2), 183-190.
Pitte, J. D., dan Kerr, E.A., 2006, The Impact of Comorbid Chronic Condition on
Diabetes Care, Diabetes Care, 29 (3), 725-731.
Qian, Y., Lin, Y., Zhang, T., Chen, F., Zhang, Y., Luo, S., Shen, H., 2010, The
characteristic of impaired fasting glucose associated with obesity and
dyslipidemia in a Chinesse population, BMC Pubic Health, 10, 139.
Sarifah, S., 2014, Faktor-faktor yang mempengaruhi masih tingginya kadar gula
darah pasien diabetes meellitus yang menjalani terapi diabetes mellitus di
Poliklinik Penyakit Dalam RSUP dr. Sardjito Yogyakarta, Jurnal
Kesehatan Profesi Profesional Islami, 7, 21-29.
Saseen, J.J., dan Carter, B.L., 2005, Hypertension, dalam: DiPiro, J.T., Talbert,
R.L., Yee, G.C., Matzke, G.R., Wells, B.G., dan Posey, L.M.,
Pharmacoteraphy a Pathophysiological Approach, 6th Edition, 185-217,
Appleton and Lange, Stamford Connecticut.
Schutta, M.H., 2007, Diabetes and Hypertension: Epidemiology of the
Relationship nd Pathophysiology of Factor Associated With These
Comorbid Conditition, JCMC Spring, 2:124-130.
 HUBUNGAN DRUG RELATED PROBLEMS DENGAN OUTCOME TERAPI PADA PASIEN DIABETES
MELITUS TIPE 2 DENGAN 94
HIPERTENSI RAWAT INAP DI RUMAH SAKIT PKU MUHAMMADIYAH YOGYAKARTA
SUGENG RUSPANDI
Universitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/

Schwinghammer, T.L., 2000, Hypertension in Dipiro, et al. Parmacoterapy

Handbook, 2rd Edition, 94-113, Appleton and Lange, Stamford.
Schwinghammer, T.L., 2012a, Dyslipidemia, dalam Wells, B.G., Dipiro, J.T.,
Schwinghammer, T.L., DiPiro, C.V., Pharmacotherapy Handbook, 8th
edition, 356-413, McGraw-Hill, New York.
Schwinghammer, T.L., 2012b, Gout and Hyperuricemia, dalam Wells, B.G.,
Dipiro, J.T., Schwinghammer, T.L., DiPiro, C.V., Pharmacotherapy
Handbook, 8th edition, 31-64, McGraw-Hill, New York.
Shaw, J.E., Sicree, R.A., dan Zimmet, P.Z., 2010, Global estimate of the
prevalence of diabetes for 2010 and 2030, Diabetes Res Clin Pract, 87, 4-
14.
Struijs, J. N., Baan, C. A., Schellevis, F. G., Westert, G.P., Bos, G. A. M., 2006,
Comorbidity in Patient with Diabetes Mellitus: Impact on Medical Health
Care Utilization, BMC Health Care Services Research, 6, 84.
Tatro, D.S., 2009, Drug Interaction Facts, Wolters Kluwers Health. Inc,
California.
Thomas, M.C., MacIsaac, R.J., Tsalamandris, C., Power, D., Jerume, G., 2003,
Uncategorized Anemia in Patient With Diabetes, Diabetes Care, 26 (4),
1164-1169.
Tjay, H.T., dan Rahardja, K., 2007, Obat-Obat Penting, PT Elex Media
Komputindo Gramedia, Jakarta.
Tosi, F., Muggeo, M., Brun, E., Spiazzi, E., Perobelli, L., Zarolin, E., Gori, M.,
Coppini, A., Maghetti, P., 2003, Combination treatment with metformin
and glibenclamide versus single-drug therapies in type 2 diabetes mellitus :
a randomized, double-blind, comparative studies, Metabolism, 52 (7), 862-
867.
Triplitt, C. L., Reasner, C. A., Isley, W. L., 2005, Diabetes Mellitus, dalam
Dipiro, J.T., Tabert, R. L., Yee, G. C., Matzke, G. R., Wells, B. G., Posey,
L. M., (Eds), Pharmacoterapy A Pathophysiological Approach, 6th edition,
1207-1208, 1214-1226, Mc Graw Hill, New York.
Viberti, G., dan Wheeldon, N.M., 2002, Microalbuminuria Reduction With
Valsartan in Patient With Type 2 Diabetes Mellitus, Circulation, 106, 672-
678.
Weiss, A., Michael, Martha, F.M., 2009, In the Beginning: Setting the Stage for
Effective Diabetes Care, Clinical Diabetes, 27 (2), 150-151.
 HUBUNGAN DRUG RELATED PROBLEMS DENGAN OUTCOME TERAPI PADA PASIEN DIABETES
MELITUS TIPE 2 DENGAN 95
HIPERTENSI RAWAT INAP DI RUMAH SAKIT PKU MUHAMMADIYAH YOGYAKARTA
SUGENG RUSPANDI
Universitas Gadjah Mada, 2015 | Diunduh dari http://etd.repository.ugm.ac.id/

Wells, B.G., Dipiro, J.T., Schwinghammer, T.L., dan DiPiro, C.V.,

Pharmacotherapy Handbook, 8th edition, 31-64, McGraw-Hill, New
York.
Winblad, B., 2005, Piracetam: A Review of Pharmacological Properties and
Clinical Uses, CNS Drug Reviews, 11(2), 169-182.